Further, flow cytometry analysis results showed that overexpression of TAT could increase apoptosis of hepatoma cells and knocking down Smad2 could create a compensatory effect to decrease hepatoma cell apoptosis. The gene discussed is SMAD2; the disease is hepatocellular carcinoma.